This should occur when the patient is able to travel to a dental facility (Class I; Level of Evidence C). Baddour et al Infective Endocarditis in Adults 1475 Writing Group Disclosures Writing Group Member Employment Research Grant Other Research Support Speakers Bureau/ Honoraria Expert Witness Ownership Interest Consultant/ Advisory Board Other Larry M. Baddour Mayo Clinic None None None None None None None Robert S. Baltimore Yale University School of Medicine None None None None None None None Bruno Barsic Hospital for Infectious Diseases, School of Medicine Zagreb None None Astellas*; Pfizer*; MSD* None None None None Arnold S. Bayer LA Biomedical Research Institute Infectious Diseases Astellas ; Cubist ; NIH/NIAID*; Theravance* None None Johnson Graffe et al*; Morrow, Kidman, Tinker et al*; Galloway, Lucchese et al*; MES Solutions*; Hoffman, Sheffield et al*; Clifford Law* None None None Ann F. Bolger UCSF None None None None None None None Anne M. Fink University of Illinois at Chicago None None None None None None None Vance G. Fowler, Jr. Duke University CDC ; Cerexa/Forest ; MedImmune ; NIH ; FDA ; Cubist* None None Witness in case involving group B Streptococcal Vertebral osteomyelitis None MedImmune*; Novartis ; The Medicines Comapy*; Novadigm*; Debiopharm*; Cerexa*;Affinium*; Tetraphase*; Bayer*; Theravance*; Cubist*; Genetech*; Basilea* None Michael H. Gewitz New York Medical College None None None None None None None Matthew E. Levison Drexel University College of Medicine None None None None None Merck Manual None Peter B. Lockhart Carolinas Medical Center None None None None None None None Patrick O Gara Brigham and Women s Hospital None None None None None None None Michael J. Rybak Wayne State University Cubist*; Forest*; MDCH*; NIH*; Actavis*; Theravance* None Cubist*; Forest*; Novartis*; Actavis*; The Medicines Company* None None Cubist*; Forest*; Theravance*; Actavis ; The Medicines Company* None James M. Steckelberg Mayo Clinic None None None None None None None Kathryn A. Taubert American Heart Association None None None None None None None Imad M. Tleyjeh King Fahd Medical City None None None None None None None Walter R. Wilson Mayo Clinic None None None None None None None This table represents the relationships of writing group members that may be perceived as actual or reasonably perceived conflicts of interest as reported on the Disclosure Questionnaire, which all members of the writing group are required to complete and submit. 